Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhang, Xiongliang ^a   Yan, Xiaoyu ^a   Cheng, Liang ^a   Dai, Jiezhi ^a   Wang, Chunyang ^a   Han, Pei ^a   Chai, Yimin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MIMOSINE; PROLYLHYDROXYLASE DOMAIN 2 PROTEIN; REGULATOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; FIBROBLAST; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; CYTOKINES; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE SILENCING; GREEN FLUORESCENT PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HYPOXIA-INDUCIBLE FACTOR-PROLINE DIOXYGENASES; MICE; MICE, INBRED NOD; MIMOSINE; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84893185949     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084548     Document Type: Article

References (40)

1. Hoogwerf BJ (2001) Postoperative management of the diabetic patient. Med Clin North Am 85: 1213-1228. doi:10.1016/S0025-7125(05)70373-4. PubMed: 11565495.
2. Apelqvist J (2012) Diagnostics and treatment of the diabetic foot. Endocrine 41: 384-397. doi:10.1007/s12020-012-9619-x. PubMed: 22367583.
3. McLaughlin PJ, Immonen JA, Zagon IS (2013) Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis. Exp Biol Med (Maywood), 238: 733-43. PubMed: 23788174.
4. Hewitson KS, Schofield CJ (2004) The HIF pathway as a therapeutic target. Drug Discov Today 9: 704-711. doi:10.1016/S1359-6446(04)03202-7. PubMed: 15341784. (Pubitemid 39070283)
5. Bárdos JI, Ashcroft M (2005) Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta 1755: 107-120. PubMed: 15994012. (Pubitemid 40982561)
6. Desta T, Li J, Chino T, Graves DT (2010) Altered fibroblast proliferation and apoptosis in diabetic gingival wounds. J Dent Res 89: 609-614. doi:10.1177/0022034510362960. PubMed: 20354230.
7. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z et al. (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93: 1074-1081. doi:10.1161/01.RES. 0000102937.50486.1B. PubMed: 14576200. (Pubitemid 37485038)
8. Wang P, Qi H, Sun C, He W, Chen G et al. (2013) Overexpression of Hypoxia-Inducible Factor-1alpha Exacerbates Endothelial Barrier Dysfunction Induced by Hypoxia. Cell Physiol Biochem 32: 859-870. doi:10.1159/000354488. PubMed: 24081113.
9. Aprelikova O, Chandramouli GV, Wood M, Vasselli JR, Riss J et al. (2004) Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem 92: 491-501. doi:10.1002/jcb.20067. PubMed: 15156561.
10. Fong GH, Takeda K (2008) Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ 15: 635-641. doi:10.1038/cdd.2008.10. PubMed: 18259202.
11. Steinhoff A, Pientka FK, Möckel S, Kettelhake A, Hartmann E et al. (2009) Cellular oxygen sensing: Importins and exportins are mediators of intracellular localisation of prolyl-4-hydroxylases PHD1 and PHD2. Biochem Biophys Res Commun 387: 705-711. doi:10.1016/j.bbrc.2009.07.090. PubMed: 19631610.
12. Smith TG, Talbot NP (2010) Prolyl hydroxylases and therapeutics. Antioxid Redox Signal 12: 431-433. doi:10.1089/ars.2009.2901. PubMed: 19761407.
13. Fraisl P, Aragonés J, Carmeliet P (2009) Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 8: 139-152. doi:10.1038/nrd2761. PubMed: 19165233.
14. Scherr M, Morgan MA, Eder M (2003) Gene silencing mediated by small interfering RNAs in mammalian cells. Curr Med Chem 10: 245-256. doi:10.2174/0929867033368493. PubMed: 12570711. (Pubitemid 36131657)
15. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE et al. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811. doi:10.1038/35888. PubMed: 9486653. (Pubitemid 28099681)
16. Lee E, Kim DY, Chung E, Lee EA, Park KS et al. (2013) Transplantation of cyclic stretched fibroblasts accelerates the wound-healing process in streptozotocin-induced diabetic mice. Cell Transplant: ([MedlinePgn:]) PubMed: 23394853.
17. Darby IA, Hewitson TD (2007) Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 257: 143-179. doi:10.1016/S0074-7696(07)57004-X. PubMed: 17280897. (Pubitemid 46186476)
18. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J et al. (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271. doi:10.1016/0092-8674(95)90151-5. PubMed: 8548812. (Pubitemid 26007816)
19. Peters AS, Brunner G, Blumbach K, Abraham DJ, Krieg T et al. (2012) Cyclic mechanical stress downregulates endothelin-1 and its responsive genes independently of TGFbeta1 in dermal fibroblasts. Exp Dermatol 21: 765-770. PubMed: 23078398.
20. Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K (1997) A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 44: 1299-1305. doi:10.1016/S0039-9140(97) 00017-9. PubMed: 18966866. (Pubitemid 27249311)
21. Galiano RD, Michaels Jt, Dobryansky M, Levine JP, Gurtner GC (2004) Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 12: 485-492. doi:10.1111/j.1067-1927.2004.12404.x. PubMed: 15260814. Available online at: doi:10.1111/j.1067-1927.2004.12404.x Available online at: PubMed: 15260814
22. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN et al. (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887. doi:10.1093/jnci/84.24.1875. PubMed: 1281237. (Pubitemid 23004615)
23. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341: 738-746. doi:10.1056/NEJM199909023411006. PubMed: 10471461. (Pubitemid 29407375)
24. Siqueira MF, Li J, Chehab L, Desta T, Chino T et al. (2010) Impaired wound healing in mouse models of diabetes is mediated by TNF-alpha dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia 53: 378-388. doi:10.1007/s00125-009-1529-y. PubMed: 19902175.
25. Vogler M, Vogel S, Krull S, Farhat K, Leisering P et al. (2013) Hypoxia Modulates Fibroblastic Architecture, Adhesion and Migration: A Role for HIF-1alpha in Cofilin Regulation and Cytoplasmic Actin Distribution. PLOS ONE 8: e69128. doi:10.1371/journal.pone.0069128. PubMed: 23874890.
26. Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL et al. (2004) Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279: 38458-38465. doi:10.1074/jbc.M406026200. PubMed: 15247232. (Pubitemid 39295997)
27. Kalucka J, Ettinger A, Franke K, Mamlouk S, Singh RP et al. (2013) Loss of Epithelial HIF Prolyl Hydroxylase-2 (PHD2) Accelerates Skin Wound Healing in Mice. Mol Cell Biol.
28. Takeda K, Fong GH (2007) Prolyl hydroxylase domain 2 protein suppresses hypoxia-induced endothelial cell proliferation. Hypertension 49: 178-184. doi:10.1161/01.HYP.0000251360.40838.0f. PubMed: 17101841. (Pubitemid 46360358)
29. Kato H, Inoue T, Asanoma K, Nishimura C, Matsuda T et al. (2006) Induction of human endometrial cancer cell senescence through modulation of HIF-1alpha activity by EGLN1. Int J Cancer 118: 1144-1153. doi:10.1002/ijc. 21488. PubMed: 16161047. (Pubitemid 43185600)
30. Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA 3rd (2006) Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res 98: 133-140. PubMed: 16306444. (Pubitemid 43970213)
31. Mollenhauer M, Kiss J, Dudda J, Kirchberg J, Rahbari N et al. (2012) Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy. Langenbecks Arch Surg 397: 1313-1322. doi:10.1007/s00423-012-0998- 5. PubMed: 22961008.
32. Müller HD, Cvikl B, Gruber R, Watzek G, Agis H (2012) Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor in dental pulp-derived cells. J Endod 38: 1498-1503. doi:10.1016/j.joen. 2012.08.003. PubMed: 23063224.
33. Agis H, Watzek G, Gruber R (2012) Prolyl hydroxylase inhibitors increase the production of vascular endothelial growth factor by periodontal fibroblasts. J Periodontal Res 47: 165-173. doi:10.1111/j.1600-0765.2011.01415.x. PubMed: 21954882.
34. Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL et al. (2012) L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells. Am J Physiol Cell Physiol 302: C676-C685. doi:10.1152/ajpcell.00180.2011. PubMed: 22116304.
35. Higuchi Y, Kawakami S, Hashida M (2010) Strategies for in vivo delivery of siRNAs: recent progress. BioDrugs 24: 195-205. doi:10.2165/11534450- 000000000-00000. PubMed: 20462284.
36. Choung S, Kim YJ, Kim S, Park H-O, Choi Y-C (2006) Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem Biophys Res Commun 342: 919-927. doi:10.1016/j.bbrc.2006.02.049. PubMed: 16598842. (Pubitemid 43320485)
37. Behlke MA (2008) Chemical modification of siRNAs for in vivo use. Oligonucleotides 18: 305-319. doi:10.1089/oli.2008.0164. PubMed: 19025401. (Pubitemid 352791344)
38. Corey DR (2007) Chemical modification: the key to clinical application of RNA interference? J Clin Invest 117: 3615-3622. doi:10.1172/JCI33483. PubMed: 18060019.
39. Subramanya S, Kim SS, Manjunath N, Shankar P (2010) RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA? Expert Opin Biol Ther 10: 201-213. doi:10.1517/14712590903448158. PubMed: 20088715.
40. Takahashi Y, Yamaoka K, Nishikawa M, Takakura Y (2009) Quantitative and temporal analysis of gene silencing in tumor cells induced by small interfering RNA or short hairpin RNA expressed from plasmid vectors. J Pharm Sci 98: 74-80. doi:10.1002/jps.21398. PubMed: 18452181.